SciClone Pharmaceuticals (Holdings) Limited (赛生药业控股有限公司) is an enterprise in Hong Kong SAR, China, with the main office in Shanghai. It operates in the Pharmaceutical and Medicine Manufacturing sector. It was incorporated on May 13, 2020. It currently has a total number of 1,050 (2023) employees. The latest financial highlights indicate a net sales revenue increase of 9.52% in 2023. Its’ total assets recorded a negative growth of 8.96%. The net profit margin of SciClone Pharmaceuticals (Holdings) Limited (赛生药业控股有限公司) increased by 4.44% in 2023.
Headquarters
22/F, Central Plaza, 381 Middle Huaihai Road
Shanghai; Shanghai;
Contact Details: Purchase the SciClone Pharmaceuticals (Holdings) Limited (赛生药业控股有限公司) report to view the information.
Website: http://www.sciclone.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service